List of Chapters/Sections(Table Of Content)
1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Overview and Scope of Large Volume Parenteral (LVP)
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Global Large Volume Parenteral (LVP) Sales Comparison by Application: (2021-2027)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2016-2027
1.4.2 Global Large Volume Parenteral (LVP) Sales 2016-2027
1.4.3 Large Volume Parenteral (LVP) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
2.5 Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.5.1 Large Volume Parenteral (LVP) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Large Volume Parenteral (LVP) Players Market Share by Revenue
2.5.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Large Volume Parenteral (LVP) Retrospective Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.3.1 North America Large Volume Parenteral (LVP) Sales by Country
3.3.2 North America Large Volume Parenteral (LVP) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 Europe Large Volume Parenteral (LVP) Sales by Country
3.4.2 Europe Large Volume Parenteral (LVP) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Region
3.5.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region
3.5.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.6.1 Latin America Large Volume Parenteral (LVP) Sales by Country
3.6.2 Latin America Large Volume Parenteral (LVP) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country
3.7.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Large Volume Parenteral (LVP) Historic Market Analysis by Type
4.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
4.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2021)
4.3 Global Large Volume Parenteral (LVP) Price by Type (2016-2021)
5 Global Large Volume Parenteral (LVP) Historic Market Analysis by Application
5.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
5.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2016-2021)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Baxter Healthcare
6.1.1 Baxter Healthcare Corporation Information
6.1.2 Baxter Healthcare Description and Business Overview
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.1.5 Baxter Healthcare Recent Developments/Updates
6.2 Kelun Pharma
6.2.1 Kelun Pharma Corporation Information
6.2.2 Kelun Pharma Description and Business Overview
6.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
6.2.5 Kelun Pharma Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Fresenius
6.4.1 Fresenius Corporation Information
6.4.2 Fresenius Description and Business Overview
6.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
6.4.5 Fresenius Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Pfizer (Hospira)
6.6.1 Pfizer (Hospira) Corporation Information
6.6.2 Pfizer (Hospira) Description and Business Overview
6.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
6.6.5 Pfizer (Hospira) Recent Developments/Updates
6.7 Ostuka Pharmaceutical
6.6.1 Ostuka Pharmaceutical Corporation Information
6.6.2 Ostuka Pharmaceutical Description and Business Overview
6.6.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.7.5 Ostuka Pharmaceutical Recent Developments/Updates
6.8 CR Double-Crane
6.8.1 CR Double-Crane Corporation Information
6.8.2 CR Double-Crane Description and Business Overview
6.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
6.8.5 CR Double-Crane Recent Developments/Updates
6.9 Pisa
6.9.1 Pisa Corporation Information
6.9.2 Pisa Description and Business Overview
6.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
6.9.5 Pisa Recent Developments/Updates
6.10 Huaren
6.10.1 Huaren Corporation Information
6.10.2 Huaren Description and Business Overview
6.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
6.10.5 Huaren Recent Developments/Updates
6.11 Patheon
6.11.1 Patheon Corporation Information
6.11.2 Patheon Large Volume Parenteral (LVP) Description and Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Patheon Recent Developments/Updates
6.12 Beximco Pharma
6.12.1 Beximco Pharma Corporation Information
6.12.2 Beximco Pharma Large Volume Parenteral (LVP) Description and Business Overview
6.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Beximco Pharma Recent Developments/Updates
6.13 Albert David
6.13.1 Albert David Corporation Information
6.13.2 Albert David Large Volume Parenteral (LVP) Description and Business Overview
6.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Albert David Recent Developments/Updates
6.14 PSI Ltd
6.14.1 PSI Ltd Corporation Information
6.14.2 PSI Ltd Large Volume Parenteral (LVP) Description and Business Overview
6.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.14.5 PSI Ltd Recent Developments/Updates
6.15 Ozon Pharmaceuticals
6.15.1 Ozon Pharmaceuticals Corporation Information
6.15.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Description and Business Overview
6.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.15.5 Ozon Pharmaceuticals Recent Developments/Updates
6.16 BAG Healthcare
6.16.1 BAG Healthcare Corporation Information
6.16.2 BAG Healthcare Large Volume Parenteral (LVP) Description and Business Overview
6.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.16.5 BAG Healthcare Recent Developments/Updates
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Corporation Information
6.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Description and Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments/Updates
7 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
7.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
7.4 Large Volume Parenteral (LVP) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Large Volume Parenteral (LVP) Distributors List
8.3 Large Volume Parenteral (LVP) Customers
9 Large Volume Parenteral (LVP) Market Dynamics
9.1 Large Volume Parenteral (LVP) Industry Trends
9.2 Large Volume Parenteral (LVP) Growth Drivers
9.3 Large Volume Parenteral (LVP) Market Challenges
9.4 Large Volume Parenteral (LVP) Market Restraints
10 Global Market Forecast
10.1 Large Volume Parenteral (LVP) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Type (2022-2027)
10.2 Large Volume Parenteral (LVP) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Application (2022-2027)
10.3 Large Volume Parenteral (LVP) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
